While currently receiving chemotherapy with mitoxantrone for Gleason grade 7 prostate cancer, a 64-year-old man presented with rectal bleeding.
While currently receiving chemotherapy with mitoxantrone for Gleason grade 7 prostate cancer, a 64-year-old man presented with rectal bleeding. His medical history included non–small-cell lung cancer, for which he had undergone pneumonectomy; type 2 diabetes mellitus; and coronary artery disease. He had undergone coronary artery bypass grafting in the past.
The patient had a mild fever, tachycardia, and hypotension. Crepitus in his perineal area was found on palpation. Absolute neutrophil count was 650/µL. Despite appropriate initial resuscitation and prophylaxis with piperacillin/tazobactam and clindamycin, the patient decompensated, and he was intubated.
CT scans of the abdomen and pelvis showed a large prostatic mass without delineation between the prostate, rectum, and bladder. A fistula was noted between the rectum and bladder (A, B, and C). Copious subcutaneous gas was visible in the perineum and in all 3 corpora of the penis (D). Blood cultures were positive for Clostridium perfringens. Necrotizing fasciitis was diagnosed, and the patient underwent a loop colostomy.
The follow-up CT scans of the abdomen and pelvis depicted dramatic improvement (E). The extraluminal gas had nearly resolved. The patient’s clinical course was ultimately favorable, and he was discharged.
FDA Proposed Rule Would Limit Nicotine Content in Cigarettes, Cigars, Other Combusted Products
January 16th 2025The agency estimates that limiting nicotine levels could lead to 1.8 million fewer tobacco-related deaths by 2060 and health care savings of $1.1 trillion a year over the next 40 years.